Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKlenner, MA-
dc.contributor.authorDarwish, TA-
dc.contributor.authorFraser, BH-
dc.contributor.authorMassi, M-
dc.contributor.authorPascali, G-
dc.identifier.citationKlenner, M. A., Darwish, T., Fraser, B. H., Massi, M., & Pascali, G. (2020). Labeled rhenium complexes: radiofluorination, α-MSH cyclization, and deuterium substitutions. Organometallics, 39(13), 2334-2351. doi:10.1021/acs.organomet.0c00267en_US
dc.description.abstractWhile radiopharmaceuticals incorporating rhenium-188 or rhenium-186 radioisotopes have been well documented in the literature, the labeling of rhenium complexes with alternative isotopes has received comparatively less attention. Such rhenium complexes have demonstrated significant utility in imaging melanoma tumors via complexation with α-melanocyte-stimulating hormone (α-MSH) analogues conjugated with radiometals and radiohalogens, improving fluorine-18 incorporation into ligands which were otherwise unable to be synthesized and elucidating improved understandings of rhenium mechanisms and coordination sites through deuterium incorporation. This review highlights each of these rhenium-labeling cases and discusses the benefits derived therein, thus providing a useful resource for researchers intending to label unique rhenium complexes. © 2020 American Chemical Societyen_US
dc.publisherAmerican Chemical Societyen_US
dc.titleLabeled rhenium complexes: radiofluorination, α-MSH cyclization, and deuterium substitutionsen_US
dc.typeJournal Articleen_US
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.